What are the treatments for secondary liver cancer? What are the non-surgical treatments for liver cancer?

What are the treatments for secondary liver cancer?

Surgical resection is the first choice for the treatment of early liver cancer, but not all liver cancer patients are suitable for surgery. Only patients with good cardiopulmonary function, localized liver tumors, no metastasis conditions, and no contraindications to surgery are suitable for surgery. For other stages of liver cancer, the efficacy of surgery is equivalent to ablation or intervention, but it causes greater damage to patients. Therefore, non-surgical treatment is generally recommended for mid- and late-stage liver cancer.

Interventional therapy is the first choice for patients with advanced liver cancer whose tumors are confined to the liver. Since the liver receives dual blood supply from the hepatic artery and portal vein, the blood flow is extremely abundant. Local targeted drug perfusion, tumor vascular embolization, and argon-helium cryoablation are used to kill tumor cells in a concentrated manner. In combination with CIK cell adoptive immunotherapy and anti-tumor angiogenesis drugs, good clinical treatment effects have been achieved. It can also reverse the liver cancer stage of some patients and convert unresectable liver cancer cases into resectable liver cancer cases.

Because the lesion is located in the liver, TCM treatment often causes patients to have poor appetite, slow upper abdominal distension, weight loss and fatigue. In addition, the patient's body is often damaged during the treatment process, the vital energy is greatly damaged, and the body fluid is obviously depleted. At this time, TCM should focus on nourishing yin and strengthening the body, and never attack cancer blindly. The patient's physical condition should be taken seriously, and cancer may worsen if the body is weak. By promoting blood circulation and removing stasis, softening and dispersing nodules, and promoting blood circulation, anti-cancer Chinese medicine can be used together to target tumor lesions and improve the microcirculation of lesions, which can promote the shrinkage of tumors. Taking TCM for treatment can control and regulate the patient's physical recovery, inhibit tumors, and assist other treatment methods to proceed smoothly. Chinese medicine is of great significance to treatment and is applicable to the entire treatment process.

What are the non-surgical treatments for liver cancer?

For liver cancer patients who cannot undergo surgical treatment for various reasons, treatment methods include radiofrequency ablation, microwave ablation, intra-arterial chemoembolization, alcohol injection, cryotherapy, radiotherapy, etc.

Radiofrequency ablation or microwave ablation treatment technology for liver cancer: The principle of the two methods is to use the thermal effect of microwaves or radio frequencies to heat the liver tissue through the oscillation of polar molecules in the tissue, especially water molecules, thereby causing thermal coagulation in the target area, that is, burning the tumor to death, and ultimately achieving a radical effect comparable to liver cancer resection and liver transplantation.

These two treatment methods are suitable for three types of liver cancer patients: first, patients with smaller single liver cancer; second, patients with liver cancer that recurs after surgical resection; and third, patients with liver cancer who have poor liver function reserve and cannot tolerate surgical resection.

Hepatic artery interventional chemoembolization method: through arterial catheterization to reach the hepatic artery, inject embolic agents or anticancer drugs. It is often used for patients with advanced liver cancer who cannot be surgically removed to control the disease and prolong the patient's survival.

For liver cancer patients who are not suitable for hepatic artery intervention and liver cancer patients after certain palliative surgery, combined or sequential chemotherapy can be used, but the effect is not good.

Clinical trial results at home and abroad have shown that sorafenib, a new molecular targeted drug that has emerged in recent years, can delay tumor progression and, to a certain extent, prolong the patient's survival by 2-3 months. However, the drug is accompanied by more serious adverse reactions such as diarrhea, rash, and hypertension.